H Olsson|J Ranstam - JoVE Visualize

Showing results (11-20 of 481) with videos related to

Pageof 49

Sort By:

Anticancer Research|November 1, 1991

Survival in breast cancer and age at start of oral contraceptive usageJ Ranstam, H Olsson, J P Garne, et al.

Cancer Detection and Prevention|January 1, 1991

Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern SwedenH Olsson, A Borg, M Fernö, et al.

Anticancer Research|July 1, 1987

Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early ageH Olsson, B Lindahl, J Ranstam, et al.

Journal of the American Society of Nephrology : JASN|May 22, 1998

Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvementK W Westman, P G Bygren, H Olsson, et al.

Genetic Epidemiology|April 29, 1998

Analysis of Swedish male breast cancer family data: a simple way to incorporate a common sibling effectP M Karunaratne, R C Elston, N Loman, et al.

Anticancer Research|January 1, 1990

Increased plasma prolactin levels in a group of men with breast cancer--a preliminary studyH Olsson, P Alm, K Aspegren, et al.

Medical Oncology and Tumor Pharmacotherapy|January 1, 1986

A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancerH Olsson, A Borg, S B Ewers, et al.

Cancer Genetics and Cytogenetics|March 1, 1987

Prognostic implication of cytogenetic findings in 106 patients with non-Hodgkin lymphomaU Kristoffersson, S Heim, N Mandahl, et al.

Cancer|March 1, 1991

Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortionsH Olsson, J Ranstam, B Baldetorp, et al.

British Journal of Cancer|November 1, 1990

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levelsH Sigurdsson, B Baldetorp, A Borg, et al.

Pageof 49

Showing results (11-20 of 481) with videos related to

Sort By:

Pageof 49

Anticancer Research|November 1, 1991

Survival in breast cancer and age at start of oral contraceptive usageJ Ranstam, H Olsson, J P Garne, et al.

Cancer Detection and Prevention|January 1, 1991

Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern SwedenH Olsson, A Borg, M Fernö, et al.

Anticancer Research|July 1, 1987

Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early ageH Olsson, B Lindahl, J Ranstam, et al.

Journal of the American Society of Nephrology : JASN|May 22, 1998

Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvementK W Westman, P G Bygren, H Olsson, et al.

Genetic Epidemiology|April 29, 1998

Analysis of Swedish male breast cancer family data: a simple way to incorporate a common sibling effectP M Karunaratne, R C Elston, N Loman, et al.

Anticancer Research|January 1, 1990

Increased plasma prolactin levels in a group of men with breast cancer--a preliminary studyH Olsson, P Alm, K Aspegren, et al.

Medical Oncology and Tumor Pharmacotherapy|January 1, 1986

A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancerH Olsson, A Borg, S B Ewers, et al.

Cancer Genetics and Cytogenetics|March 1, 1987

Prognostic implication of cytogenetic findings in 106 patients with non-Hodgkin lymphomaU Kristoffersson, S Heim, N Mandahl, et al.

Cancer|March 1, 1991

Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortionsH Olsson, J Ranstam, B Baldetorp, et al.

British Journal of Cancer|November 1, 1990

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levelsH Sigurdsson, B Baldetorp, A Borg, et al.

Pageof 49